摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(2-甲氧基苯基)-2H-吡唑-3-胺 | 149246-82-2

中文名称
5-(2-甲氧基苯基)-2H-吡唑-3-胺
中文别名
3-(2-甲氧基苯基)吡唑-5-胺
英文名称
3-(2-methoxyphenyl)-1H-pyrazol-5-amine
英文别名
5-(2-methoxyphenyl)-1H-pyrazol-3-amine
5-(2-甲氧基苯基)-2H-吡唑-3-胺化学式
CAS
149246-82-2
化学式
C10H11N3O
mdl
MFCD02664277
分子量
189.217
InChiKey
QRAXSEJMMGAXBS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    63.9
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933199090

SDS

SDS:bdaaf42036982d931ac13d4e695f2c00
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Amino-5-(2-methoxyphenyl)-1H-pyrazole
Synonyms: 3-(2-Methoxyphenyl)-1H-pyrazol-5-amine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Amino-5-(2-methoxyphenyl)-1H-pyrazole
CAS number: 149246-82-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11N3O
Molecular weight: 189.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-(2-甲氧基苯基)-2H-吡唑-3-胺吡啶三乙胺 作用下, 以 氯仿 为溶剂, 反应 3.0h, 生成
    参考文献:
    名称:
    Novel potent neuropeptide Y Y5 receptor antagonists: Synthesis and structure–activity relationships of phenylpiperazine derivatives
    摘要:
    A series of phenylpiperazine derivatives were synthesized and evaluated for their neuropeptide Y (NPY) Y5 receptor antagonistic activities. The benzindane portion of 2 was replaced by I-phenylpiperazine, resulting in novel urea derivative X Subsequent optimization of the phenylpiperazine template by substitution of the phenyl moiety resulted in a series of (2-methanesulfonamidephenyl)piperazine derivatives that showed potent binding affinity and antagonistic activity for the Y5 receptor. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.07.023
  • 作为产物:
    描述:
    2-甲氧基苯甲酰乙腈 作用下, 以 乙醇 为溶剂, 以59%的产率得到5-(2-甲氧基苯基)-2H-吡唑-3-胺
    参考文献:
    名称:
    7-(氨基烷基)吡唑并[1,5-a]嘧啶衍生物作为组织蛋白酶K抑制剂的合成及生物学评价。
    摘要:
    合成了一系列新颖的7-氨基烷基取代的吡唑并[1,5-a]嘧啶衍生物,并测试了其对组织蛋白酶K的抑制作用。合成方法包括用N-Boc-α-氨基酸衍生的炔酮环化5-氨基吡唑通过酯和Boc-氨基官能团的转化。它使得吡唑并[1,5-a]嘧啶支架易于在各种位置上多样化。还进行了与吡唑并[1,5-a]嘧啶衍生物的分子对接研究,以阐明组织蛋白酶K活性位点的结合模式。合成的化合物表现出中等的抑制活性(Ki≥77μM)。
    DOI:
    10.1016/j.bioorg.2018.11.029
  • 作为试剂:
    描述:
    参考文献:
    名称:
    3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
    摘要:
    本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调制和/或抑制异常细胞增殖。
    公开号:
    US07005444B2
点击查看最新优质反应信息

文献信息

  • [EN] POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER<br/>[FR] AMIDES POLYCYCLIQUES UTILISÉS EN TANT QUE MODULATEURS D'UBE2K POUR LE TRAITEMENT DU CANCER
    申请人:BERG LLC
    公开号:WO2021138540A1
    公开(公告)日:2021-07-08
    Provided are compounds of Formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.
    提供的是Formula (I)的化合物及其药用盐和组合物,可用于治疗与UBE2K调节相关的疾病。
  • THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE
    申请人:Suzuki Masaki
    公开号:US20150307477A1
    公开(公告)日:2015-10-29
    Methods of treating disorders using compounds that modulate striatal-enriched tyrosine phosphatase (STEP) are described herein. Exemplary disorders include schizophrenia and cognitive deficit.
    本文描述了利用调节纹状体富集的酪氨酸磷酸酶(STEP)的化合物来治疗疾病的方法。示例疾病包括精神分裂症和认知缺陷。
  • 3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    申请人:Allergan, Inc.
    公开号:US06559173B1
    公开(公告)日:2003-05-06
    The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调控、调节和/或抑制异常细胞增殖。
  • Design, synthesis, and evaluation of 2-aryl-7-(3′,4′-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidines as novel PDE-4 inhibitors
    作者:Ikyon Kim、Jong Hwan Song、Chang Min Park、Joon Won Jeong、Hyung Rae Kim、Jin Ryul Ha、Zaesung No、Young-Lan Hyun、Young Sik Cho、Nam Sook Kang、Dong Ju Jeon
    DOI:10.1016/j.bmcl.2009.12.070
    日期:2010.2
    is design, synthesis, and biological evaluation of novel series of 2-aryl-7-(3′,4′-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidines acting as inhibitors of type 4 phosphodiesterase (PDE4) which is known as a good target for the treatment of asthma and COPD. For this purpose, structure optimization was conducted with the aid of structure-based drug design using the known X-ray crystallography. Also, biological
    本文描述了新颖的2-芳基-7-(3',4'-二烷氧基苯基)-吡唑并[1,5- a ]嘧啶系列的新颖系列的设计,合成和生物学评估,该抑制剂可作为4型磷酸二酯酶(PDE4)的抑制剂被认为是治疗哮喘和COPD的好靶标。为此目的,使用已知的X射线晶体学,借助于基于结构的药物设计进行结构优化。此外,通过使用体外测定法评估了这些化合物对目标酶的生物学作用,从而产生了有效且选择性的PDE-4抑制剂(IC 50  <10 nM)。
  • Synthesis of pyrazolopyrimidinones using a “one-pot” approach under microwave irradiation
    作者:Mark Kelada、John M D Walsh、Robert W Devine、Patrick McArdle、John C Stephens
    DOI:10.3762/bjoc.14.104
    日期:——
    A simple one-pot method for the microwave-assisted synthesis of substituted pyrazolo[1,5-a]pyrimidinones, a core scaffold in many bioactive and pharmaceutically relevant compounds, has been established. A variety of substituents was tolerated at the 2 and 5 positions, including functionalized aryls, heterocycles, and alkyl groups.
    建立了一种简单的一锅法,用于微波辅助合成取代的吡唑并[1,5-a]嘧啶酮(一种在许多生物活性和药学相关的化合物中的核心骨架)。在2和5位上可以耐受各种取代基,包括官能化的芳基,杂环和烷基。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺